Clinical trial
Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer…
NCT00496392 · Nycomed, Industry · Completed
Key facts
| NCT number | NCT00496392 |
|---|---|
| Title | Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM) |
| Official title | An Open Label, Comparative, Randomised, Balanced Crossover Trial Comparing Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq®) in Breakthrough Pain in Patients With Cancer |
| Lead sponsor | Nycomed, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Nasal fentanyl |
| Enrollment | 115 |
| Start date | Jan 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Jul 4, 2007 |
| Last update posted | May 7, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: